TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer.

Nathan A Pennell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.